Nipecotic Acid CAS 498-95-3 Hoobkas High Purity
Chaw tsim tshuaj paus Supply nrog siab purity thiab ruaj khov zoo, coj mus muag ntau lawm
Tshuaj npe | Nipecotic acid |
Synonyms | DL-Nipecotic acid;3-Piperidinecarboxylic Acid;H-DL-Nip-OH |
CAS Nr | 498-95-3 : kuv |
CAT Number | Qauv TSIS MUAJ: RF-PI284 |
Tshuag xwm txheej | Nyob rau hauv Tshuag, ntau lawm Scale mus txog Tons |
Molecular Formula | C6H11NO2 |
Molecular Luj | 129.16 Nws |
Dej Solubility | Soluble hauv dej |
Shipping Condition | Shipped nyob rau hauv ambient kub |
Hom | Ruifu Tshuaj |
Yam khoom | Specifications |
Qhov tshwm sim | Dawb los yog daj crystalline hmoov |
Decompose Kub | ≥261.0 ℃ |
Kev txheeb xyuas | IR, NMR |
Poob rau ziab | ≤ 1.0% |
Residue ntawm Ignition | ≤ 1.0% |
Assay / Analysis Method | ≥98.0% (TLC) |
Test Standard | Enterprise Standard;Suav Pharmacopoeia (CP) |
Kev siv | Pharmaceutical Intermediates |
Pob: Lub raj mis, Aluminium ntawv ci hnab, Cardboard Nruas, 25kg / Nruas, los yog raws li tus neeg yuav tsum tau muaj.
Cia txias:Khaws rau hauv cov thawv ntim khoom ntawm qhov chaw txias thiab qhuav;Tiv thaiv los ntawm lub teeb, noo noo thiab kab tsuag.
Shanghai Ruifu Chemical Co., Ltd. yog cov chaw tsim khoom thiab cov chaw muag khoom ntawm Nipecotic Acid (CAS: 498-95-3) nrog cov khoom zoo, dav siv hauv cov organic synthesis, synthesis ntawm cov tshuaj intermediates thiab Active Pharmaceutical Ingredient (API) synthesis.Nipecotic Acid (CAS: 498-95-3) yog qhov muaj peev xwm inhibitor ntawm γ-aminobutyric acid (GABA) nyob rau hauv nas hlwb slices.Lipophilic derivatives ntawm nipecotic acid yog siv los ua tshuaj rau kev kho mob qaug dab peg.
Daim ntawv thov
Nipecotic acid tau siv rau hauv kev txiav txim siab ntawm cov tshuaj antiepileptic vigabatrin thiab cov amino acid neurotransmitters hauv nas hlwb extracellular kua los ntawm capillary;electrophoresis nrog laser-induced fluorescence nrhiav pom;Reactant rau concurrent esterification thiab N-acteylation ntawm amino acids nrog orthoesters
Reactant rau synthesis ntawm:
Anticonvulsants:HCV NS5B polymerase inhibitors;Cathepsin S inhibitors;Qhov ncauj bioavailable P2Y12 antagonists rau inhibition ntawm platelet aggregation;Zoo allosteric modulator ntawm metabotropic glutamate receptor 4